Stock Events

Stock Events

Armata Pharmaceuticals 

€9.8
6
-€0.4-3.92% Friday 13:08

Statistics

Day High
9.6
Day Low
9.6
52W High
10.8
52W Low
0.7
Volume
-
Avg. Volume
-
Mkt Cap
356.03M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
-0.74
-0.54
-0.35
-0.15
Expected EPS
-0.38
Actual EPS
N/A

Financials

-363.67%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
9.76MRevenue
-35.48MNet Income

Analyst Ratings

11.38Average Price Target
The highest estimate is 11.38.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TG1N.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Scynexis
SCYX
Mkt Cap44.66M
SCYNEXIS, Inc. is involved in developing innovative therapies to treat fungal infections, competing in the broader anti-infective market alongside Armata Pharmaceuticals.

About

Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.
Show more...
CEO
Dr. Deborah L. Birx M.D.
Employees
60
Country
United States
ISIN
US04216R1023
WKN
000A2PKLC

Listings

STU
DE
TG1N.STU
MU
DE
TG1N.MU
F
DE
TG1N.F
XASE
US
ARMP

0 Comments

Share your thoughts

FAQ

What is Armata Pharmaceuticals stock price today?▼
The current price of TG1N.F is €9.8 EUR — it has decreased by -3.92% in the past 24 hours. Watch Armata Pharmaceuticals stock price performance more closely on the chart.
What is Armata Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Armata Pharmaceuticals stocks are traded under the ticker TG1N.F.
Is Armata Pharmaceuticals stock price growing?▼
TG1N.F stock has risen by +7.1% compared to the previous week, the month change is a +17.37% rise, over the last year Armata Pharmaceuticals has showed a +942.55% increase.
What is Armata Pharmaceuticals market cap?▼
Today Armata Pharmaceuticals has the market capitalization of 356.03M
When is the next Armata Pharmaceuticals earnings date?▼
Armata Pharmaceuticals is going to release the next earnings report on May 07, 2026.
What were Armata Pharmaceuticals earnings last quarter?▼
TG1N.F earnings for the last quarter are -0.64 EUR per share, whereas the estimation was -0.36 EUR resulting in a -76.19% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Armata Pharmaceuticals revenue for the last year?▼
Armata Pharmaceuticals revenue for the last year amounts to 9.76M EUR.
What is Armata Pharmaceuticals net income for the last year?▼
TG1N.F net income for the last year is -35.48M EUR.
How many employees does Armata Pharmaceuticals have?▼
As of April 18, 2026, the company has 60 employees.
In which sector is Armata Pharmaceuticals located?▼
Armata Pharmaceuticals operates in the Health & Wellness sector.
When did Armata Pharmaceuticals complete a stock split?▼
The last stock split for Armata Pharmaceuticals was on May 10, 2019 with a ratio of 1:14.
Where is Armata Pharmaceuticals headquartered?▼
Armata Pharmaceuticals is headquartered in Los Angeles, United States.